General
Biotech giant to slash 3000 jobs, spin-off vaccine arm
Australian pharmaceutical giant CSL will cut as many as 3000 jobs and spin-off its flu vaccine arm into a separate business in a bid to shave $500 million from its bottom line.
The…
Continue Reading
-
Noosa News23 hours agoTop chefs rally for Noosa Reds farmers Pete and Dory
-
General17 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
Business17 hours agoUp 44% since April, why this dividend paying ASX 300 energy stock could keep running hot
-
Noosa News14 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man